About
BreakSight develops and commercializes technology to capture and sequence DNA double-strand break sites across the genome, providing genomic analysis tools to support cancer research, drug development, biomarker discovery, and aging research.
Explore BreakSight's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.